Jay Raisen, MD
Otolaryngology · Scarborough, MENPI 1740305473
Payments from drug & device makers
What this record shows
Stryker accounts for 67.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $2,083 and has fallen 87.4% since, to $262 in 2024.
Across 41 payments — averaging $85.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Preceptis Medical, Inc.$242
- Alk-abello, Inc$235
- GSK$226
- Medtronic$133
- AstraZeneca$83
- plus $206 from 5 others
Across 4 payments — averaging $7064.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Preceptis Medical, Inc.$28K
What the payments were for
- Travel & lodging$1,79651%
- Food & beverage$1,71349%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $2,384 |
| Preceptis Medical, Inc. | 4 | $242 |
| Alk-abello, Inc | 2 | $235 |
| GSK | 5 | $226 |
| Medtronic | 3 | $133 |
| AstraZeneca | 1 | $83 |
| Aerin Medical Inc. | 2 | $74 |
| Optinose US, Inc. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Intersect ENT, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPRESS ENT DILATION SYSTEM$1,922
- Hummingbird TTS$175
- Odactra$139
How this compares
$3,510 in reported general payments places this provider in the 80th percentile of 42 otolaryngology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 111 | $1,119 |
| Ipratropium Bromide | 33 | $1,054 |
| Doxycycline Hyclate | 45 | $868 |
| Cefdinir | 33 | $805 |
| Ofloxacin | 15 | $747 |
| Acetic Acid | 22 | $466 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 48 | $456 |
| Levocetirizine Dihydrochloride | 30 | $407 |
| Clarithromycin | 17 | $397 |
| Azelastine Hcl | 23 | $279 |
| Montelukast Sodium | 30 | $231 |
| Methylprednisolone | 14 | $65 |
| Omeprazole | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Scarborough
- William ReedScarborough$4K
- Rebecca HarveyScarborough$4K
- Megan AbbottScarborough$196
- Jordan MalenkeScarborough$113
- Jeffrey BedrosianPortland$727K
- Peter O'ConnorBrunswick$27K
- Stephen MaturoPortland$14K
- Elizabeth PearceFalmouth$5K
- Brian CusickAugusta$4K
- Nicholas AndresenAugusta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.